QR-koodi

Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study

Abstract Background Adjuvant targeted therapy represents the standard of care for patients with resectable epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Neoadjuvant therapy can improve surgical and survival outcomes. This study aimed to compare the effectiveness...

Täydet tiedot

Tallennettuna:
Päätekijät: Feng Li, Chaoqi Zhang, Luyu Huang, Ziming Wang, Guanchao Ye, Zhuoyu Gu, Yu Qi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2026-01-01
Sarja:BMC Cancer
Aiheet:
EGFR
NSCLC
Neoadjuvant therapy
Immunotherapy
EGFR-TKIs
Linkit:https://doi.org/10.1186/s12885-026-15582-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia